文献速递产科母胎医学

剖宫产术后阴道分娩中胎盘植入谱系的评估

Assessment of placenta accreta spectrum at vaginal birth after cesarean delivery.
PubMed 文献 · Am J Obstet Gynecol MFM · 2023-08-03

本研究基于美国全国住院患者样本回顾性分析2017至2020年间184415例有低位横切口剖宫产史并尝试阴道分娩的患者,发现剖宫产术后阴道分娩时胎盘植入谱系发生率为每万次分娩8.1例,且与产后出血、输血、休克或凝血病及子宫切除等严重母体并发症相关;低置胎盘与胎盘植入谱系风险升高关联最强。

要点

  • 剖宫产术后阴道分娩时胎盘植入谱系发生率为每万次分娩8.1例,多数为胎盘植入(83.3%)。
  • 低置胎盘与胎盘植入谱系风险升高关联最强(校正比值比35.02,95%置信区间18.19-67.42)。
  • 胎盘植入谱系组产后出血、输血、休克或凝血病及子宫切除率均高于无胎盘植入谱系组(均P<.001)。

核心结论

  • 剖宫产术后阴道分娩时胎盘植入谱系虽不常见(1229例中1例),但诊断与显著母体并发症相关。
  • 数据提示,既往低位横切口剖宫产者若存在低置胎盘,在尝试引产前应仔细评估可能的胎盘植入谱系。

研究设计与样本

  • 回顾性查询医疗成本与利用项目全国住院患者样本,纳入2017至2020年间184415例有低位横切口剖宫产史且本次住院经阴道分娩的患者。
  • 排除前置胎盘、既往垂直剖宫产、其他子宫瘢痕及子宫破裂者,采用国际疾病分类第十版代码O43.2识别胎盘植入谱系。
  • 采用多因素二元逻辑回归模型评估临床与妊娠特征,采用倾向性评分调整分析分娩结局,并进行系统文献综述(检索PubMed、Cochrane和Scopus)。

主要发现

  • 剖宫产术后阴道分娩时胎盘植入谱系发生率为每万次分娩8.1例,多数为胎盘植入(83.3%)。
  • 多因素分析中,高龄产妇、吸烟、子痫前期、多胎妊娠、胎儿畸形、未足月胎膜早破、绒毛膜羊膜炎、低置胎盘和早产均与胎盘植入谱系风险升高相关(均P<.05)。
  • 低置胎盘与胎盘植入谱系的比值比最大(每万次分娩526.3例 vs 7.3例;校正比值比35.02;95%置信区间18.19-67.42)。
  • 胎盘植入谱系组较无胎盘植入谱系组更易发生产后出血(80.0% vs 5.5%)、血制品输注(23.3% vs 1.0%)、休克或凝血病(20.0% vs 0.2%)及子宫切除(43.3% vs <0.1%)(均P<.001)。
  • 系统文献综述共筛选212项研究,均未探讨剖宫产术后阴道分娩时胎盘植入谱系的发生率及发病率。

临床怎么用

  • 作者认为,既往低位横切口剖宫产者若存在低置胎盘,在尝试引产前应仔细评估可能的胎盘植入谱系。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Previous cesarean delivery is a risk factor for developing placenta accreta spectrum in a subsequent pregnancy and patients with antenatally suspected placenta accreta spectrum frequently undergo planned cesarean hysterectomy. There is a paucity of data regarding unsuspected placenta accreta spectrum among patients undergoing trial of labor after cesarean delivery for attempted vaginal birth after cesarean delivery. OBJECTIVE: This study aimed to investigate the incidence, characteristics, and delivery outcomes of patients with placenta accreta spectrum diagnosed at the time of vaginal birth after cesarean delivery. STUDY DESIGN: The Healthcare Cost and Utilization Project's National Inpatient Sample was retrospectively queried to examine 184,415 patients with a history of low transverse cesarean delivery who had vaginal delivery in the current index hospital admission between 2017 and 2020. Those with placenta previa, previous vertical cesarean delivery, other uterine scars, and uterine rupture were excluded. This study identified placenta accreta spectrum cases using the World Health Organization International Classification of Disease, Tenth Revision, codes of O43.2. Coprimary outcomes were (1) the incidence rate of placenta accreta spectrum at vaginal birth after cesarean delivery; (2) clinical and pregnancy characteristics related to placenta accreta spectrum, assessed with multivariable binary logistic regression model; and (3) delivery outcomes associated with placenta accreta spectrum by fitting propensity score adjustment. The secondary outcome was to conduct a systematic literature review using 3 public search engines (PubMed, Cochrane, and Scopus). Data on incidence rate and maternal morbidity related to placenta accreta spectrum at vaginal birth after cesarean delivery were evaluated. RESULTS: The incidence rate of placenta accreta spectrum at vaginal birth after cesarean delivery was 8.1 per 10,000 deliveries. Most placenta accreta spectrum cases were placenta accreta (83.3%). In a multivariable analysis, older maternal age, tobacco use, preeclampsia, multifetal pregnancy, fetal anomaly, preterm premature rupture of membrane, chorioamnionitis, low-lying placenta, and preterm delivery were associated with an increased risk of placenta accreta spectrum (all, P<.05). Of these factors, low-lying placenta had the largest odds for placenta accreta spectrum (526.3 vs 7.3 per 10,000 deliveries; adjusted odds ratio, 35.02; 95% confidence interval, 18.19-67.42). Patients in the placenta accreta spectrum group were more likely to have postpartum hemorrhage (80.0% vs 5.5%), blood product transfusion (23.3% vs 1.0%), shock or coagulopathy (20.0% vs 0.2%), and hysterectomy (43.3% vs <0.1%) than those without placenta accreta spectrum (all, P<.001). In a systematic literature review, a total of 212 studies were screened, and none of these studies examined the incidence and morbidity of placenta accreta spectrum at vaginal birth after cesarean delivery. CONCLUSION: This nationwide assessment suggests that although placenta accreta spectrum with vaginal birth after cesarean delivery is uncommon (1 of 1229 cases), the diagnosis of placenta accreta spectrum at vaginal birth after cesarean delivery is associated with significant maternal morbidity. In addition, the data suggest that low-lying placenta in the setting of previous low transverse cesarean delivery warrants careful evaluation for possible placenta accreta spectrum before a trial of labor.

来源:Am J Obstet Gynecol MFM,查看原文。版权归原作者所有。

引用

  1. Matsuzaki S, Rau AR, Mandelbaum RS, et al. Assessment of placenta accreta spectrum at vaginal birth after cesarean delivery. Am J Obstet Gynecol MFM. 2023. PMID: 37543142. doi:10.1016/j.ajogmf.2023.101115

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。